{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 12,
        "end": 17
      }
    },
    {
      "id": "T3",
      "obj": "Disease",
      "span": {
        "begin": 63,
        "end": 79
      }
    },
    {
      "id": "T4",
      "obj": "Disease",
      "span": {
        "begin": 82,
        "end": 84
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 227,
        "end": 238
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 243,
        "end": 256
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 227,
        "end": 256
      }
    },
    {
      "id": "T10",
      "obj": "Chemical",
      "span": {
        "begin": 259,
        "end": 269
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "20122728_2",
  "text": "The role of TNF-a promoter polymorphisms in the development of multiple myeloma ( MM ) were tested in 210 patients and 218 healthy individuals and their impact on the clinical outcome were evaluated in 98 patients treated with thalidomide and dexamethasone ( Thal + Dex ) regimen ."
}
